SUNNYVALE, California, April 17, 2018 /PRNewswire/ -- Unique Hologram Technology Will Showcase the Benefits Accuray Radiotherapy Systems and Software Solutions Provide to Patients

Accuray Incorporated (Nasdaq: ARAY) announced today it will be showcasing the benefits of its radiotherapy systems and software solutions at the 37th annual European Society for Radiotherapy and Oncology (ESTRO) meeting in Barcelona, Spain. The meeting, to be held April 20-24, 2018, will attract more than 3,000 radiation oncology professionals who will gather to gain information and insights on the latest developments in radiation therapy. Accuray will be in attendance at booth #1700, sharing information on new treatment approaches and providing opportunities for conversations about how the company's innovative CyberKnife® and Radixact® Systems, and advanced software solutions, can help improve the radiation therapy treatment experience for clinicians and their patients.

"This year, Accuray has chosen a theme which is anchored in our company culture and conveys our new corporate positioning: 'Innovating Patient-First Cancer Treatment.' This is not just a tagline. It is who we are, what we do and what makes us different. As the fight against cancer grows more complex, we will continually introduce new thinking and fresh tools to drive patient outcomes to entirely new levels," said Lionel Hadjadjeba, M.D., Senior Vice President, and Chief Commercial Officer at Accuray.
Special Events: Accuray Booth #1700

Accuray is building on its history of innovation with a new approach for demonstrating product features and benefits, and a new award recognizing customer advances achieved with its products.

April 21, 2018 at 9:30 a.m.: Unveiling of hologram technology, "viRTual - Where Art Meets Science"

April 21, 2018 at 2:10 p.m.: Announcement of first annual ESTRO Accuray Innovation Awards

Accuray ESTRO37 Highlights: Advances in Software Solutions

VOLO™ Technology for the CyberKnife System: a state-of-the art optimizer that simplifies the process of creating treatment plans, improves plan quality and enables more efficient exploration of the tradeoffs between treatment time and plan quality. Preliminary data indicates that the VOLO technology will provide a significant reduction in optimization time, as well as a reduction in overall treatment time. Technology under development for the CyberKnife System - not available for sale.
CTrue™ IR (Iterative Reconstruction) for the Radixact System: this new image guidance software improves soft-tissue contrast and reduces noise, enhancing image quality, while maintaining the same low imaging dose and fast reconstruction time as earlier versions of the software. Patient workflows are also more efficient, facilitating the delivery of precise treatments more quickly, for more patients.

Health IT Homepage